Rockwell Medical Inc (NASDAQ:RMTI) — Market Cap & Net Worth
Market Cap & Net Worth: Rockwell Medical Inc (RMTI)
Rockwell Medical Inc (NASDAQ:RMTI) has a market capitalization of $33.09 Million ($33.09 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23357 globally and #5029 in its home market, demonstrating a 10.19% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rockwell Medical Inc's stock price $7.19 by its total outstanding shares 39470299 (39.47 Million). See Rockwell Medical Inc (RMTI) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Rockwell Medical Inc Market Cap History: 2015 to 2026
Rockwell Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $4.45 Billion to $283.79 Million (-23.97% CAGR).
Index Memberships
Rockwell Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #665 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2213 of 3165 |
Weight: Rockwell Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Rockwell Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rockwell Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.48x
Rockwell Medical Inc's market cap is 0.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.84 Billion | $53.28 Million | -$19.80 Million | 53.37x | N/A |
| 2017 | $2.53 Billion | $57.30 Million | -$25.92 Million | 44.10x | N/A |
| 2018 | $981.23 Million | $63.39 Million | -$32.13 Million | 15.48x | N/A |
| 2019 | $1.06 Billion | $61.30 Million | -$34.13 Million | 17.28x | N/A |
| 2020 | $438.52 Million | $62.20 Million | -$30.89 Million | 7.05x | N/A |
| 2021 | $178.01 Million | $61.93 Million | -$32.67 Million | 2.87x | N/A |
| 2022 | $40.06 Million | $72.81 Million | -$18.68 Million | 0.55x | N/A |
| 2023 | $74.60 Million | $83.61 Million | -$8.44 Million | 0.89x | N/A |
| 2024 | $80.52 Million | $101.49 Million | -$480.00K | 0.79x | N/A |
| 2025 | $32.90 Million | $69.26 Million | -$5.31 Million | 0.48x | N/A |
Competitor Companies of RMTI by Market Capitalization
Companies near Rockwell Medical Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Rockwell Medical Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Rockwell Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Rockwell Medical Inc's market cap moved from $4.45 Billion to $ 283.79 Million, with a yearly change of -23.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $283.79 Million | +762.63% |
| 2025 | $32.90 Million | -59.14% |
| 2024 | $80.52 Million | +7.94% |
| 2023 | $74.60 Million | +86.21% |
| 2022 | $40.06 Million | -77.49% |
| 2021 | $178.01 Million | -59.41% |
| 2020 | $438.52 Million | -58.61% |
| 2019 | $1.06 Billion | +7.96% |
| 2018 | $981.23 Million | -61.17% |
| 2017 | $2.53 Billion | -11.15% |
| 2016 | $2.84 Billion | -36.04% |
| 2015 | $4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Rockwell Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.09 Million USD |
| MoneyControl | $33.09 Million USD |
| MarketWatch | $33.09 Million USD |
| marketcap.company | $33.09 Million USD |
| Reuters | $33.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate conce… Read more